This report focuses on NDD market opportunities in Asia, Europe, US and the
RoW.
The report provides an in-depth presentation of recent developments
(2000-2010) in nanoparticle-enabled DDS and future opportunities (2011-2021).
Persons with a financial or academic interest in the pharmaceutical industry
who want to learn how advances in nanotechnology research and development will
impact the economics of the pharmaceutical market will benefit most from this
report.
This report will focus on a geographical breakdown of the developed NDD TAM
for the period 2000-2010, with a forecast NDD TAM for the period 2011-2021.
The values are presented in $USD as well as percentages.
In the decade since the international spotlight focused on nanotechnology,
with some predicting a trillion dollar nanotech-enabled market by 2020, it has
become increasingly clear from which areas of science and industry that market
will materialise. Cientifica's Global Funding of Nanotechnologies 2011
tracked the growth of government funding to a total of $67.5 billion from 2000
to 2011.
Nanotechnology in Drug Delivery: Global Markets, indicates
nanotech-enabled drug delivery therapeutics is set to grow from a current
value of $2.3 billion to $136 billion by the year 2021. This sector will
therefore represent approximately 15% of the global nanotechnology market in
2021. Healthcare offers the greatest opportunity to add value to nanomaterials
and China is the fastest-growing market sector.
Cientifica's research indicates that global growth in the drug delivery market
will be led by Asia with a compound annual growth rate (CAGR) of 32.5% between
now and 2021. China will be the largest market for nanotechnology based drug
delivery systems by 2021, worth more than $18 billion and representing 43% of
the Asian market.
France is forecast to surpass Japan as a drug delivery market within 10 years.
Among European Union countries, the highest growth will be found in the former
Eastern Bloc, and the lowest in the UK.
Table of Contents
Table of Contents
Executive Summary
Chapter 1
Report Scope
Thematic Scope
Scope of Data Analysis
Temporal Scope of Analysis
Geographical Scope
Report objective
Methodology
Calculation of CAGR
The Nanoscale
Chapter 2
Overview of nanotechnology
What are the Key Drivers for Adoption of Nanotechnology in Medicine and
Biomedicine?
The Key Applications of Nanotechnology in Medicine and Biomedicine
How Nanotechnology Can Benefit Drug Delivery
How Nanotechnology Is Already Having An Impact On The Drug Delivery Sector
Chapter 3
Three Key Barriers to The Adoption of Nanotechnology in Medicine and
Biomedicine
Five Current & Future Challenges in The Adoption of Nanotechnology in
Medicine and Biomedicine
Chapter 4
Global Market Analysis: 2000-2010 (Without Segmentation)
Global Market Forecast: 2011-2021 (Without Segmentation)
Market Analysis Countries and Regions: 2000-2010 (With Segmentation)
Market Forecast Countries and Regions: 2011-2021 (With Segmentation)
Appendix
Publishing activity by organization (2000-2010)
Table of Exhibits
Chapter One
Exhibit 1.1
Formula for the calculation of the Compound Annual Growth Rate (CAGR),
(top).
Formula for the calculation of the Compound Annual Growth Rate (CAGR) in
this report, for the 2011-2021 period, (bottom) [2].
Exhibit 1.2
Formula for the verification of the calculated values of the Compound
Annual Growth Rate (CAGR), (top).
Formula for the verification of the calculated values of the Compound
Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom)
[2].
Exhibit 1.3
Nanometres in a meter (top). Meters in a nanometre (bottom).
Chapter Two
Exhibit 2.1
The periodic table of elements, as we know it (at meter scale) is
governed by classic Newtonian laws of physics. However, when perceived at
nanoscale, those elements are governed by the laws of quantum physics.
Exhibit 2.2
Proportion of the population aged over 65 and over 80 [7].
Exhibit 2.3
Illustration of a diagram of each property of nanocarriers (size, shape,
surface chemistry and mechanical properties) and their parameters subjected
to optimization in order to improve their efficiency [10].
Chapter Three
Exhibit 3.1
Specified expected barriers in the development of particular types of
nanoparticles (Courtesy of CienNanoroadmap Synthesis Report), [6].
Exhibit 3.2
Illustration of the measures adoption roadmap to combat/attenuate the
key barriers to the adoption of nanotechnology in medicine and biomedicine
(Source: Cientifica, Ltd.).
Exhibit 3.3
Table representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in drug delivery, without segmentation, source: Cientifica
(all figures US$ Million Dollars).
Exhibit 3.4
Line chart representing Total Addressable Market, TAM (2000-2010), for
nanotechnology in drug delivery, without segmentation, source: Cientifica
(all figures US$ Million Dollars).
Exhibit 3.5
Bar chart representing Total Addressable Market, TAM (2000-2010), for
nanotechnology in drug delivery, without segmentation, source: Cientifica
(all figures US$ Million Dollars).
Exhibit 3.6
Table representing the Total Addressable Market, TAM forecast by 2021
(for the 2011-2021 period), for nanotechnology in drug delivery, without
segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.7
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery,
without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.8
Bar chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery,
without segmentation, source: Cientifica (all figures US$ Million Dollars).
Chapter Four:
Exhibit 4.8
Table representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in drug delivery, all countries studied, source: Cientifica
(all figures US$ Million Dollars).
Exhibit 4.9
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, by world regions and countries, source:
Cientifica (all figures in percentage).
Exhibit 4.10
Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in drug delivery, by world regions and countries,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.11
Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, by world regions and countries, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.12
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000-2010), for nanotechnology in drug delivery, by world
regions and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.13
3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010), for nanotechnology in drug delivery, by world regions and
countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.14
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, all world regions and countries
studied, source: Cientifica (all figures in percentage).
Exhibit 4.15
Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in drug delivery, all world regions and countries
studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.16
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, European Union countries studied,
source: Cientifica (all figures in percentage)
Exhibit 4.17
Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in drug delivery, European Union countries studied,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.18
Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, European Union countries studied,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.19
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union
countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.20
3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010), for nanotechnology in drug delivery, European Union countries
studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.21
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, Asian countries studied, source:
Cientifica (all figures in percentage).
Exhibit 4.22
Horizontal bar graph representing the Total Addressable Market, TAM In
2010, for nanotechnology in drug delivery, Asian countries studied, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.23
Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, Asian countries studied, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.24
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian
countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.25
3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010), for nanotechnology in drug delivery, Asian countries studied,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.46
Table representing the Total Addressable Market, TAM forecast by 2021
(for the 2011-2021 period), for nanotechnology in drug delivery, by world
regions / countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.47
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, by world regions, source:
Cientifica (all figures in percentage).
Exhibit 4.48
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, by world regions,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.49
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by
world regions, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.50
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, by world regions, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.51
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, by world regions, source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.52
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, by all world regions / countries
studied, source: Cientifica (all figures in percentage).
Exhibit 4.53
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, by all world regions
/ countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.54
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all
world regions / countries studied, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.55
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, by all world regions / countries studied, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.56
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, by all world regions / countries studied, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 4.57
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, European Union countries studied,
source: Cientifica (all figures in percentage).
Exhibit 4.58
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, European Union
countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.59
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery,
European Union countries studied, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.60
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, European Union countries studied, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 4.61
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, European Union countries studied, source: Cientifica (all figures
US$ Million Dollars).
Exhibit 4.62
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, Asian countries studied, source:
Cientifica (all figures in percentage).
Exhibit 4.63
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, Asian countries
studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.64
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian
countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.65
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, Asian countries studied, source: Cientifica (all figures
US$ Million Dollars).
Exhibit 4.66
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, Asian countries studied, source: Cientifica (all figures US$
Million Dollars).
Appendix
Exhibit A.1
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: North America; country: USA.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.2
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: European Union; country:
Germany.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.3
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: European Union; country:
France.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.4
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: European Union; country: UK.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.5
Table of publishing activity in PubMed periodicals (2000-2010), based on
PubMed, for Nanotechnology in Drug Delivery. Country: Russian Federation.
Organizations are ordered alphabetically (increasing order).
Exhibit A.6
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: India.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.7
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: India.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.8
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: Japan.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.9
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: P R China.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.10
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: South Korea
(Republic of Korea).
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.11
Table of publishing activity in PubMed periodicals (2000-2010), based on
PubMed, for Nanotechnology in Drug Delivery. Asia; country: Taiwan.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Nanotechnology in Drug Delivery: Global Markets published by Cientifica Ltd in January 16, 2012. This report consists of 121 Pages and the price starts from US $ 1599.
Press Release
Nanotech-Enabled Drug Delivery Therapeutics Set to Grow to $136 Billion by 2021
February 2nd, 2012
Global Information Inc. would like to present a new market research report, "Nanotechnology in Drug Delivery: Global Markets" by Cientifica Ltd.
In the decade since the international spotlight focused on nanotechnology, with some predicting a trillion dollar nanotech-enabled market by 2020, it has become increasingly clear from which areas of science and industry that market will materialize. Cientificas Global Funding of Nanotechnologies 2011 tracked the growth of government funding to a total of $67.5 billion from 2000 to 2011.
Cientificas latest report, "Nanotechnology in Drug Delivery: Global Markets," indicates nanotech-enabled drug delivery therapeutics is set to grow from a current value of $2.3 billion to $136 billion by the year 2021. This sector will therefore represent approximately 15% of the global nanotechnology market in 2021. Healthcare offers the greatest opportunity to add value to nanomaterials and China is the fastest-growing market sector, according to Cientifica.
"Its a win-win situation for the nanotechnology and pharmaceutical industries," said Tim Harper, CEO of Cientifica. "Drug delivery offers higher margins than other uses of nanomaterials, and allows manufacturers to access more of the value chain than if they were supplying materials for paint or sunscreen. At the same time, reformulation of drugs can enable the pharma industry to extend patents and hang on to existing revenue streams."
Cientificas research indicates that global growth in the drug delivery market will be led by Asia with a compound annual growth rate (CAGR) of 32.5% between now and 2021. China will be the largest market for nanotechnology based drug delivery systems by 2021, worth more than $18 billion and representing 43% of the Asian market.
France is forecast to surpass Japan as a drug delivery market within 10 years. Among European Union countries, the highest growth will be found in the former Eastern Bloc, and the lowest in the UK.
"While early ideas about the impact of nanotechnology on healthcare focused on fanciful ideas involving small submarines and cancer-zapping robots, current advances have been enabled by advances in imaging, control over materials and an increased understanding of how biology works at the nanoscale," said Harper.
